RECK expression in osteosarcoma: Correlation with matrix metalloproteinases activation and tumor invasiveness
RECK expression in osteosarcoma: Correlation with matrix metalloproteinases activation and tumor invasiveness
复制标题
DOI:
10.1002/jor.20323
复制
发表时间:
2007-05-01
影响因子:
2.8
通讯作者:
Han, Ilkyu
中科院分区:
文献类型:
--
作者:
Kang, Hyun-Guy;Kim, Han-Soo;Han, Ilkyu
Osteosarcoma is a malignant tumor of bone characterized by its high metastatic potential. For the development of metastasis, activation of matrix metalloprotemases (NIMPS) is required. A novel MMPs inhibitor, reversion inducing eysteine rich protein with Kazal motifs (RECK), is known to down-regulate MMPs and suppress the invasive and metastatic potential in many tumor-derived cell lines and some types of tumors. The expression of RECK and its role in tumor invasiveness have never been studied in osteosarcoma. We examined RECK mRNA expression and MMPs activation in osteosarcoma using quantitative real time PCR, gelatin zymography, invasion assay, and transfection experiments. RECK was expressed but down-regulated in osteosarcoma cells. Activation of pro-MMP-2 was observed in all samples, whereas activation of MMP-2 and pro-MMP-9 was detected in only 11% and 7% of the samples, respectively. MMP-9 was not activated in any of the samples. The level of RECK expression was inversely correlated with pro-MMP-2 activation, and overexpression of RECK by transfection resulted in decreased pro-MMP-2 activation and reduced tumor invasiveness. These findings suggest that RECK plays an important role in the invasiveness of osteosarcoma. (c) 2007 Orthopaedic Research Society.